Advertisement · 728 × 90

Posts by Velindre Library

Preview
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial The addition of relacorilant to nab-paclitaxel led to significantly longer overall survival in patients with platinum-resistant ovarian cancer, without the need for biomarker selection. The findings s...

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant #OvarianCancer (ROSELLA): a phase 3 randomised controlled trial. www.thelancet.com/journals/lan...

6 days ago 0 0 0 0
Preview
Systemic Treatment of Thyroid Cancer: ASCO Guideline ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual. ASCO Guidelines follow ...

Systemic Treatment of Thyroid Cancer: ASCO Guideline ascopubs.org/doi/10.1200/... #Cancer

1 week ago 0 0 0 0
Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial In ARASENS, risk of death was significantly reduced by 32.5% with darolutamide in combination with androgen deprivation therapy (ADT) and docetaxel (hazard ratio [HR], 0.68; 95% confidence interval [CI], 0.57–0.80; p < 0.001) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). We assessed efficacy and safety of darolutamide in European patients from ARASENS.

Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial www.ejcancer.com/article/S095... #Cancer

1 week ago 0 0 0 0

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial www.bmj.com/content/392/... #Cancer

1 week ago 0 0 0 0
Uveal melanoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up† Uveal melanoma (UM) is associated with specific challenges due to its rare incidence. Optimal management of the disease requires multidisciplinary collaboration and coordination for the diagnosis, treatment, follow-up and support of patients at all stages and clearly established referral pathways.1 All patients should have access to centres with dedicated expertise in primary and metastatic UM either nationally or through cross-border access agreements, using the potential of the existing and forthcoming European Reference Networks as outlined in Europe’s Beating Cancer Plan, the ambition of the European Union (EU) Cancer Mission and the establishment and connection of Comprehensive Cancer Care Infrastructures in the EU.

Uveal melanoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up www.esmoopen.com/article/S205... #CAncer

1 week ago 0 0 0 0
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial Prognosis is poor and treatment options are limited for patients with previously untreated, advanced triple-negative breast cancer (TNBC), especially for those who are not candidates for immunotherapy.

Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02) www.annalsofoncology.org/article/S092... #Cancer

1 week ago 0 0 0 0
Preview
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology Vaccine-preventable infections remain a major cause of morbidity and mortality in patients with cancer. The updated guideline for anti-infective vaccination strategies in patients with cancer of the German Society of Hematology and Medical Oncology Infectious Diseases Working Group was developed by a guideline panel of experts in internal medicine, haematology, medical oncology, and infectious diseases. For previously covered vaccinations, we included all publications in patients with cancer starting from 2017, as this was the data cutoff for the previous guideline, and for newly included vaccines all publications were reviewed.

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology & Medical Oncology www.thelancet.com/journals/lan... #Cancer

1 week ago 0 0 0 0
Preview
Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial Along with the known survival benefits, the clinically meaningful delays in pain progression and time to deterioration of overall wellbeing support consideration of darolutamide plus ADT as a standard-of-care treatment option in patients with mHSPC.

Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive #prostatecancer (ARANOTE): secondary and exploratory analyses www.thelancet.com/journals/lan... #Cancer

1 week ago 0 0 0 0
Preview
Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Global childhood cancer burden remains a substantial contributor to global childhood disease and cancer burden and is disproportionately weighted towards resource-limited settings. The estimation of additional cancer types relevant in childhood provides a step towards alignment with WHO GICC targets. Efforts to decrease global childhood cancer burden should focus on addressing the inequities in burden worldwide and support comprehensive improvements along the childhood cancer diagnosis and care continuum.

Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 www.thelancet.com/journals/lan... #Cancer

1 week ago 0 0 0 0
Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990–2019 (CONCORD-4): a Cancer Survival Index derived for 68 countries by analysis of individual records for 613 021 children from 307 population-based cancer registries The new CSI enables quantitative international comparison of trends in survival for all childhood cancers combined and for the six WHO tracer cancers, through a simple three-way standardisation by age, sex and subtype. The CSI should be a useful tool to monitor future trends. In most high-income, upper-middle-income, and lower-middle-income countries participating in CONCORD-4, the all-cancers CSI was either close to or had already passed the GICC target to reach 60% 5-year survival for all childhood cancers combined, worldwide, by 2030.

Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990–2019 (CONCORD-4) www.thelancet.com/journals/lan... #Cancer

1 week ago 0 0 0 0
Advertisement
UK real-world evidence on pembrolizumab and neoadjuvant chemotherapy for early-stage triple-negative breast cancer The KEYNOTE-522 trial showed that use of pembrolizumab-chemotherapy for stage 2-3 triple-negative breast cancer improved pathological complete respons…

UK real-world evidence on pembrolizumab and neoadjuvant chemotherapy for early-stage triple-negative #breastcancer www.sciencedirect.com/science/arti... @velindrecc.bsky.social #Cancer

1 week ago 0 0 0 0
Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab - Sumayya Anwer, Janharpreet Singh, Sylwia Bujkiewicz, Anne Thomas, Richard Adams, Elizabeth Smyth, Pedro Saramago, Stephen Palmer, Marta O. Soares, Sofia Dias, 2026 Background As an increasing number of oncology drugs are licensed for multiple indications, sharing information across indications may help improve the precisio...

Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab journals.sagepub.com/doi/10.1177/... @velindrecc.bsky.social #Cancer

1 week ago 0 0 0 0
Preview
Episode 189 Immunotherapy on the Acute Take Part 3: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician

New Immunobuddies episode Alert! Episode 189 Immunotherapy on the Acute Take Part 3: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician open.spotify.com/episode/352i... @rickyfrazer1.bsky.social @velindrecc.bsky.social

1 week ago 0 0 0 0
Preview
Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung Neuroendocrine tumors of the lung are classified into small cell lung carcinoma (SCLC), typical carcinoid, atypical carcinoid, and large cell neuroendocrine carcinoma (LCNEC) in the current World Heal...

Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung. www.lungcancerjournal.info/article/S016...

2 weeks ago 0 0 0 0
Preview
A systematic review of the implementation of cancer-specific holistic needs assessment (HNA) in adult clinical practice, and applicability to the brain tumour population - Supportive Care in Cancer Purpose This review aimed to identify and review any brain tumour-specific holistic needs assessment (HNA) and the clinical implementation of any HNAs in an adult cancer population. Methods A systemat...

A systematic review of the implementation of cancer-specific holistic needs assessment (HNA) in adult clinical practice, and applicability to the brain tumour population. @velindrecc.bsky.social link.springer.com/article/10.1...

2 weeks ago 0 0 0 0
Preview
HPV-Associated Oropharyngeal Squamous Cell Carcinoma – Key Updates to the AJCC/UICC TNM9 Staging System - Annals of Surgical Oncology Annals of Surgical Oncology -

HPV-Associated Oropharyngeal Squamous Cell Carcinoma - Key Updates to the AJCC/UICC TNM9 Staging System @velindrecc.bsky.social link.springer.com/article/10.1...

2 weeks ago 0 0 0 0
Preview
Describing and monitoring quality in value-based palliative and end-of-life care at a population level in Wales: achievements and future direction Improving and monitoring quality of palliative and end-of-life care is well documented within current and historic literature. However, there is a paucity of evidence around national data-informed app...

Describing and monitoring quality in value-based palliative and end-of-life care at a population level in Wales: achievements and future direction. @velindrecc.bsky.social spcare.bmj.com/content/earl...

2 weeks ago 0 0 0 0
Preview
A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option? Metastatic melanoma is traditionally associated with poor responses to conventional cytotoxic chemotherapy. Although there has been a shift in paradigm in melanoma treatment in the last few decades wi...

A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option? @velindrecc.bsky.social @rickyfrazer1.bsky.social www.cureus.com/articles/440...

2 weeks ago 0 0 0 0

The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the #Cancer Continuum. @velindrecc.bsky.social www.mdpi.com/2077-0383/15...

2 weeks ago 0 0 0 0
Advertisement
Preview
Aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDs) for preventing colorectal cancer and colorectal adenoma in the general population - Cai, Z - 2026 | Cochrane Library Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.

Cochrane Systematic Review: Aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDs) for preventing #ColorectalCancer and colorectal adenoma in the general population. www.cochranelibrary.com/cdsr/doi/10....

2 weeks ago 0 0 0 0
Preview
Hematological immune-related adverse events associated with checkpoint inhibitors The use of immune checkpoint inhibitors (ICIs) targeting PD-1, PD-L1, or CTLA-4 has increased considerably over the past decade. Initially introduced in the metastatic setting, ICIs are now widely use...

Hematological immune-related adverse events associated with checkpoint inhibitors. www.cancertreatmentreviews.com/article/S030...

2 weeks ago 0 0 0 0
Preview
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial Objective To determine the pre-specified long term efficacy (survival and swallowing function) and safety of medial retropharyngeal lymph node (MRLN) region sparing radiotherapy for non-metastatic nas...

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial. www.bmj.com/content/392/...

2 weeks ago 0 0 0 0
ASCO Publications

Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced #ProstateCancer Treated With Enzalutamide. ascopubs.org/doi/10.1200/...

3 weeks ago 1 0 0 0
Preview
Conventional vs. Hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMR... Advances in radiation delivery techniques have markedly enhanced the precision of tumor targeting, allowing enhanced target dose escalation, while minimizing exposure to surrounding healthy tissues [1...

Conventional vs. Hypofractionated radiotherapy for high-risk #ProstateCancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT. www.thegreenjournal.com/article/S016...

3 weeks ago 0 0 0 0
Preview
[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study 177Lu-PSMA-617 showed promising response rates and delayed disease progression in patients with oligometastatic HSPC in this trial. In addition, most treatment-related adverse events were low grade.

[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive #ProstateCancer (BULLSEYE): an open-label, randomised, phase 2 study. www.thelancet.com/journals/lan...

3 weeks ago 0 0 0 0
Preview
Episode 187 Immunotherapy on the Acute Take: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician

New Immunobuddies is here, so it must be Friday! Episode 187 Immunotherapy on the Acute Take: What Every Acute Medic Needs to Know with Dr Dan Beckett – Acute Physician. @velindrecc.bsky.social @rickyfrazer1.bsky.social open.spotify.com/episode/1Gsy...

3 weeks ago 0 0 0 0
Preview
Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial - British Journal of Cancer British Journal of Cancer - Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial

Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for #ProstateCancer: the MANCAN2 randomized controlled trial. @VelindreCS www.nature.com/articles/s41...

3 weeks ago 1 1 0 0
Overview | Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps | Guidance | NICE

NICE HealthTech Guideline [HTG773]: Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps. www.nice.org.uk/guidance/htg...

3 weeks ago 1 0 1 0
Preview
Clinical Utility of Deep Learning–based Multiple Arterial Phase MRI in Hepatocellular Carcinoma | Radiology: Imaging Cancer Compared with conventional single arterial phase MRI, deep learning–based ultrafast multiphase arterial MRI improved late arterial phase capture, image quality, and diagnostic performance for hepat...

Clinical Utility of Deep Learning–based Multiple Arterial Phase MRI in Hepatocellular Carcinoma. pubs.rsna.org/doi/10.1148/...

3 weeks ago 0 0 0 0
Advertisement
RSNA Journals | Cookie Absent

The Rise of Deepfake Medical Imaging: Radiologists’ Diagnostic Accuracy in Detecting ChatGPT-generated Radiographs. pubs.rsna.org/doi/10.1148/...

3 weeks ago 0 0 0 0